Ignite Creation Date:
2024-05-06 @ 5:04 PM
Last Modification Date:
2024-10-26 @ 2:21 PM
Study NCT ID:
NCT05186545
Status:
RECRUITING
Last Update Posted:
2022-09-02
First Post:
2021-12-23
Brief Title:
An Exploratory Study of Surufatinib Combined With Chidamide and Fulvestrant in HR Positive Unresectable Metastatic Breast Cancer
Sponsor:
The First Affiliated Hospital of Zhengzhou University
Organization:
The First Affiliated Hospital of Zhengzhou University
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Breast Cancer Female |
| Breast Cancer |
Keywords: